We recently demonstrated that celecoxib treatment of low-grade glioma cells induces apoptosis and inhibits their proliferation via the Akt/survivin and Akt/inhibitor of differentiation (Id)-3 pathways12. The gene discussed is AKT1; the disease is glioma.